Skip to main content

Table 1 Demographic characteristics of subjects

From: Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant

 

OAGV group (n = 8)

CAGV group (n = 12)

p-value

Age, years (mean ± SD)

60.9 ± 19.6

63.1 ± 14.1

0.910a

Female, patients (%)

4 (50.0%)

6 (50.0%)

0.350b

Diabetes, patients (%)

1 (12.5%)

4 (33.3%)

0.255b

Hypertension, patients (%)

2 (25.0%)

2 (16.7%)

0.381b

Diagnosis, eyes (%)

  

0.951b

 Neovascular glaucoma

1 (12.5%)

2 (16.7%)

 

 Uveitic glaucoma

1 (12.5%)

1 (8.3%)

 

 Pseudoexfoliation glaucoma

1 (12.5%)

3 (25.0%)

 

 Primary open-angle glaucoma

2 (25.0%)

4 (33.4%)

 

 Congenital glaucoma

2 (25.0%)

1 (8.3%)

 

 Primary angle-closure glaucoma

1 (12.5%)

1 (8.3%)

 

Previous glaucoma surgery, eyes (%)

4 (50.0%)

6 (50.0%)

1.000b

Preoperative IOP (mean ± SD)

33.4 ± 6.3

30.6 ± 6.8

0.238a

Number of preoperative IOP-lowering medications (mean ± SD)

3.6 ± 1.2

4.0 ± 1.2

0.473a

  1. aMann-Whitney U-test; bχ2-test; OAGV Ologen-augmented Ahmed glaucoma valve implantation, CAGV conventional Ahmed glaucoma valve implantation, SD standard deviation, IOP intraocular pressure